Avalon Biomedical

The Avalon Biomedical Group focuses on the design and development of light-related medical devices and healthcare products.

Our first product is a LED-based wearable phototherapy device (Kanga-care) for the treatment of neonatal jaundice. It was developed by a team of pediatric specialists, engineers, and scientists. Kanga-care was approved as a Class II medical device in China in 2018.

The second generation, KangaLite, featured a redesigned light emitting panels and swaddle for reducing weight and improving the product usability. KangaLite has received the approval from the China’s NMPA (formally known as CFDA), CE certificate for EU regions, and 510(k) clearance from the US FDA.

Innovations, social responsibility, create values